Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of CS02 Tablet in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone

NCT03317028 is registered in ClinicalTrials.gov with Center Laboratories, Inc. as lead sponsor.

NCT NCT03317028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03317028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of CS02 Tablet in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone
Lead sponsor
Center Laboratories, Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 10, 2017
Completion date
April 21, 2020
Enrollment
201 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

t2dm with inadequate glycemic control